- PLN363.44m
- PLN518.45m
- PLN370.57m
Brief: Selvita Unit Signs Deal With Poland's NCBiR For 11.7 Mln Zloty Subsidy
Brief: Selvita Gets EUR 0.5 Mln Order From Europe-Based Biotech Company
Brief: Pawel Przewiezlikowski Lowers His Stake In Selvita To 27.19% From 31.25%
Brief: Selvita Completes Subscription For C Series Shares
Brief: Selvita Sets C Series Shares Issue Price At 38.0 Zlotys/Shr
Brief: Selvita EGM To Vote On Raising Share Capital Via Issue Of Up To 2.4 Mln C Series Shares
Brief: Selvita Prelim Q1 Ebitda At 7.3 Mln Zlotys
Brief: Selvita Signs Prelim 10.0 Mln Zloty Net Deal To Buy Property From Ringier Axel Springer Polska
Brief: Selvita Adopts Strategy For 2020-2023
Brief: Selvita Signs Deal With Poland's NCBiR For 4.8 Mln Zloty Subsidy
Brief: Selvita Extends Cooperation With Germany-based Pharmaceutical Company
Brief: Selvita Gets Two Orders From UK-Based Pharmaceutical Company For Total Value EUR 995,505
Brief: Selvita Gets Two Deals From UK-Based Biotech Co For Total Value Of GBP 676,800